{"id":"methanthelinium","rwe":[{"pmid":"29938305","year":"2018","title":"Characterization of methanthelinium binding and function at human M(1)-M(5) muscarinic acetylcholine receptors.","finding":"","journal":"Naunyn-Schmiedeberg's archives of pharmacology","studyType":"Clinical Study"},{"pmid":"16281522","year":"2004","title":"[Randomized, placebo-controlled, double blind clinical trial for the evaluation of the efficacy and safety of oral methantheliniumbromide (Vagantin) in the treatment of focal hyperhidrosis].","finding":"","journal":"Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG","studyType":"Clinical Study"},{"pmid":"11963197","year":"2002","title":"[Oral anticholinergic therapy of focal hyperhidrosis with methanthelinium bromide (Vagantin). Initial data on effectiveness].","finding":"","journal":"Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete","studyType":"Clinical Study"},{"pmid":"13840060","year":"1959","title":"The pharmacology of a molluscan smooth muscle.","finding":"","journal":"British journal of pharmacology and chemotherapy","studyType":"Clinical Study"},{"pmid":"13536284","year":"1958","title":"A comparison of some atropine-like drugs in man, with particular reference to their end-organ specificity.","finding":"","journal":"British journal of pharmacology and chemotherapy","studyType":"Clinical Study"}],"tags":[{"label":"methantheline","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Muscarinic acetylcholine receptor","category":"target"},{"label":"CHRM1","category":"gene"},{"label":"CHRM2","category":"gene"},{"label":"CHRM3","category":"gene"},{"label":"A03AB07","category":"atc"},{"label":"Active","category":"status"},{"label":"Gastric ulcer","category":"indication"},{"label":"Peptic ulcer","category":"indication"},{"label":"Urinary incontinence","category":"indication"},{"label":"Shire","category":"company"},{"label":"Approved 1950s","category":"decade"},{"label":"Cholinergic Agents","category":"pharmacology"},{"label":"Cholinergic Antagonists","category":"pharmacology"},{"label":"Muscarinic Antagonists","category":"pharmacology"},{"label":"Neurotransmitter Agents","category":"pharmacology"}],"phase":"marketed","safety":{},"trials":[],"aliases":[],"company":"Takeda","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=methanthelinium","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:15:29.335475+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:15:36.268199+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=methanthelinium","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:15:37.054212+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201264/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:15:37.601498+00:00"}},"allNames":"banthine","offLabel":[],"synonyms":["methanthelinium bromide","banthine","methantheline","methanthelin","methanthelinium","methantheline bromide"],"timeline":[{"date":"1951-07-03","type":"positive","source":"DrugCentral","milestone":"FDA approval (Shire)"}],"approvals":[{"date":"1951-07-03","orphan":false,"company":"SHIRE","regulator":"FDA"}],"brandName":"Banthine","ecosystem":[{"indication":"Gastric ulcer","otherDrugs":[{"name":"algeldrate","slug":"algeldrate","company":"Sanofi Aventis Us"},{"name":"cimetidine","slug":"cimetidine","company":""},{"name":"famotidine","slug":"famotidine","company":"Valeant Pharms North"},{"name":"lansoprazole","slug":"lansoprazole","company":"Takeda Pharms Usa"}],"globalPrevalence":null},{"indication":"Peptic ulcer","otherDrugs":[{"name":"algeldrate","slug":"algeldrate","company":"Sanofi Aventis Us"},{"name":"almasilate","slug":"almasilate","company":""},{"name":"chlordiazepoxide","slug":"chlordiazepoxide","company":"Valeant Pharm Intl"},{"name":"dexlansoprazole","slug":"dexlansoprazole","company":"Takeda Pharms Usa"}],"globalPrevalence":64000000},{"indication":"Urinary incontinence","otherDrugs":[{"name":"flavoxate","slug":"flavoxate","company":""}],"globalPrevalence":null}],"mechanism":{"target":"Muscarinic acetylcholine receptor","novelty":"First-in-class","targets":[{"gene":"CHRM1","source":"DrugCentral","target":"Muscarinic acetylcholine receptor","protein":"Muscarinic acetylcholine receptor M1"},{"gene":"CHRM2","source":"DrugCentral","target":"Muscarinic acetylcholine receptor","protein":"Muscarinic acetylcholine receptor M2"},{"gene":"CHRM3","source":"DrugCentral","target":"Muscarinic acetylcholine receptor","protein":"Muscarinic acetylcholine receptor M3"},{"gene":"CHRM4","source":"DrugCentral","target":"Muscarinic acetylcholine receptor","protein":"Muscarinic acetylcholine receptor M4"},{"gene":"CHRM5","source":"DrugCentral","target":"Muscarinic acetylcholine receptor","protein":"Muscarinic acetylcholine receptor M5"}],"modality":"Small Molecule","drugClass":"methantheline","explanation":"","oneSentence":"","technicalDetail":"Banthine acts as a competitive antagonist at the muscarinic acetylcholine receptor, specifically targeting the M2 and M3 subtypes, thereby inhibiting the parasympathetic nervous system's effects on smooth muscle and glandular secretions."},"commercial":{"launchDate":"1951","_launchSource":"DrugCentral (FDA 1951-07-03, SHIRE)"},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1736","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=methanthelinium","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=methanthelinium","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T12:37:18.133701","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:15:39.515439+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"glycopyrronium bromide","drugSlug":"glycopyrronium-bromide","fdaApproval":"1961-08-11","relationship":"same-class"},{"drugName":"oxyphenonium","drugSlug":"oxyphenonium","fdaApproval":"","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"propantheline","drugSlug":"propantheline","fdaApproval":"1953-04-02","genericCount":10,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"tridihexethyl","drugSlug":"tridihexethyl","fdaApproval":"1954-09-15","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"isopropamide","drugSlug":"isopropamide","fdaApproval":"1957-10-09","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"hexocyclium","drugSlug":"hexocyclium","fdaApproval":"","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"mepenzolate","drugSlug":"mepenzolate","fdaApproval":"1956-11-14","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"diphemanil","drugSlug":"diphemanil","fdaApproval":"1976-05-17","patentStatus":"Unknown","relationship":"same-class"}],"genericName":"methanthelinium","indications":{"approved":[{"name":"Gastric ulcer","source":"DrugCentral","snomedId":397825006,"regulator":"FDA"},{"name":"Peptic ulcer","source":"DrugCentral","snomedId":13200003,"regulator":"FDA","usPrevalence":null,"globalPrevalence":64000000,"prevalenceMethod":"curated","prevalenceSource":"Aliment Pharmacol Ther, 2009 (PMID:19220208)"},{"name":"Urinary incontinence","source":"DrugCentral","snomedId":165232002,"regulator":"FDA"}],"offLabel":[{"name":"Irritable bowel syndrome","source":"DrugCentral","drugName":"methanthelinium","evidenceCount":0,"evidenceLevel":"emerging"}],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"glycopyrronium-bromide","brandName":"glycopyrronium bromide","genericName":"glycopyrronium bromide","approvalYear":"1961","relationship":"same-class"},{"drugId":"oxyphenonium","brandName":"oxyphenonium","genericName":"oxyphenonium","approvalYear":"","relationship":"same-class"},{"drugId":"propantheline","brandName":"propantheline","genericName":"propantheline","approvalYear":"1953","relationship":"same-class"},{"drugId":"tridihexethyl","brandName":"tridihexethyl","genericName":"tridihexethyl","approvalYear":"1954","relationship":"same-class"},{"drugId":"isopropamide","brandName":"isopropamide","genericName":"isopropamide","approvalYear":"1957","relationship":"same-class"},{"drugId":"hexocyclium","brandName":"hexocyclium","genericName":"hexocyclium","approvalYear":"","relationship":"same-class"},{"drugId":"mepenzolate","brandName":"mepenzolate","genericName":"mepenzolate","approvalYear":"1956","relationship":"same-class"},{"drugId":"diphemanil","brandName":"diphemanil","genericName":"diphemanil","approvalYear":"1976","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT01429090","phase":"PHASE1","title":"Bioavailability of Vagantin® Coated Tablets Relative to an Oral Methantheline Bromide Solution","status":"COMPLETED","sponsor":"University Medicine Greifswald","startDate":"1999-10","conditions":["Neurogenic Bladder"],"enrollment":12,"completionDate":"2000-01"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NUI":"N0000147912","NDDF":"001731","UNII":"36EI79TX7I","VUID":"4019823","CHEBI":"CHEBI:6817","VANDF":"4018127","INN_ID":"1878","RXNORM":"6821","UMLSCUI":"C0025624","chemblId":"CHEMBL1201264","ChEMBL_ID":"CHEMBL1201264","KEGG_DRUG":"D00721","DRUGBANK_ID":"DB00940","PUBCHEM_CID":"4097","SNOMEDCT_US":"21175009","SECONDARY_CAS_RN":"53-46-3","MESH_DESCRIPTOR_UI":"D000077771"},"formularyStatus":[],"_enricherVersion":"v2","_offLabelChecked":true,"developmentCodes":[],"ownershipHistory":[{"period":"1951-","companyName":"Shire","relationship":"Original Developer"}],"publicationCount":6,"therapeuticAreas":["Neuroscience"],"atcClassification":{"source":"DrugCentral","atcCode":"A03AB07","allCodes":["A03AB07"]},"biosimilarFilings":[],"originalDeveloper":"Shire","recentPublications":[{"date":"2018 Oct","pmid":"29938305","title":"Characterization of methanthelinium binding and function at human M(1)-M(5) muscarinic acetylcholine receptors.","journal":"Naunyn-Schmiedeberg's archives of pharmacology"},{"date":"2004 May","pmid":"16281522","title":"[Randomized, placebo-controlled, double blind clinical trial for the evaluation of the efficacy and safety of oral methantheliniumbromide (Vagantin) in the treatment of focal hyperhidrosis].","journal":"Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG"},{"date":"2002 Feb","pmid":"11963197","title":"[Oral anticholinergic therapy of focal hyperhidrosis with methanthelinium bromide (Vagantin). Initial data on effectiveness].","journal":"Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete"},{"date":"1959 Sep","pmid":"13840060","title":"The pharmacology of a molluscan smooth muscle.","journal":"British journal of pharmacology and chemotherapy"},{"date":"1958 Jun","pmid":"13536284","title":"A comparison of some atropine-like drugs in man, with particular reference to their end-organ specificity.","journal":"British journal of pharmacology and chemotherapy"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"Takeda","companyId":"takeda","modality":"Small Molecule","firstApprovalDate":"1951","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1951-07-03T00:00:00.000Z","mah":"SHIRE","brand_name_local":null,"application_number":""},{"country_code":"SA","regulator":"SFDA","status":"likely_approved","approval_date":"1951-07-03T00:00:00.000Z","mah":"SHIRE","brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":"1951-07-03T00:00:00.000Z","mah":"SHIRE","brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":"1951-07-03T00:00:00.000Z","mah":"SHIRE","brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":"1951-07-03T00:00:00.000Z","mah":"SHIRE","brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":"1951-07-03T00:00:00.000Z","mah":"SHIRE","brand_name_local":null,"application_number":null},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:15:39.515439+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}